Literature DB >> 1715578

Antisense oligodeoxynucleotide to the cystic fibrosis gene inhibits anion transport in normal cultured sweat duct cells.

E J Sorscher1, K L Kirk, M L Weaver, T Jilling, J E Blalock, R D LeBoeuf.   

Abstract

We have tested the hypothesis that the cystic fibrosis (CF) gene product, called the CF transmembrane conductance regulator (CFTR), mediates anion transport in normal human sweat duct cells. Sweat duct cells in primary culture were treated with oligodeoxynucleotides that were antisense to the CFTR gene transcript in order to block the expression of the wild-type CFTR. Anion transport in CFTR transcript antisense-treated cells was then assessed with a halide-specific dye, 6-methoxy-N-(3-sulfopropyl)quinolinium, and fluorescent digital imaging microscopy to monitor halide influx and efflux from single sweat duct cells. Antisense oligodeoxynucleotide treatment (3.9 or 1.3 microM) for 24 hr virtually abolished Cl- transport in sweat duct cells compared with untreated cells or control cells treated with sense oligodeoxynucleotides. Br- uptake into sweat duct cells was also blocked after a 24-hr CFTR transcript antisense treatment, but not after treatment for only 4 hr. Lower concentrations of antisense oligodeoxynucleotides were less effective at inhibiting Cl- transport. These results indicate that oligodeoxynucleotides that are antisense to CFTR transcript inhibit sweat duct Cl- permeability in both a time-dependent and dose-dependent manner. This approach provides evidence that inhibition of the expression of the wild-type CFTR gene in a normal, untransfected epithelial cell results in an inhibition of Cl- permeability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715578      PMCID: PMC52382          DOI: 10.1073/pnas.88.17.7759

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

2.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

Authors:  J T Holt; R L Redner; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects.

Authors:  G Tortora; T Clair; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.

Authors:  M L Drumm; H A Pope; W H Cliff; J M Rommens; S A Marvin; L C Tsui; F S Collins; R A Frizzell; J M Wilson
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

5.  Cl- permeability of human sweat duct cells monitored with fluorescence-digital imaging microscopy: evidence for reduced plasma membrane Cl- permeability in cystic fibrosis.

Authors:  S J Ram; K L Kirk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro.

Authors:  K Sato; F Sato
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Permeability properties of cell membranes and tight junctions of normal and cystic fibrosis sweat ducts.

Authors:  J Bijman; P Quinton
Journal:  Pflugers Arch       Date:  1987-05       Impact factor: 3.657

8.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.

Authors:  R Heikkila; G Schwab; E Wickstrom; S L Loke; D H Pluznik; R Watt; L M Neckers
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

9.  Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin.

Authors:  D Jaskulski; J K deRiel; W E Mercer; B Calabretta; R Baserga
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

10.  Differing luminal potential difference of cystic fibrosis and control sweat secretory coils in vitro.

Authors:  K Sato
Journal:  Am J Physiol       Date:  1984-10
View more
  7 in total

Review 1.  The biochemical defect in cystic fibrosis.

Authors:  A W Cuthbert
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

2.  Cystic fibrosis gene encodes a cAMP-dependent chloride channel in heart.

Authors:  P Hart; J D Warth; P C Levesque; M L Collier; Y Geary; B Horowitz; J R Hume
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Activation of endogenous deltaF508 cystic fibrosis transmembrane conductance regulator by phosphodiesterase inhibition.

Authors:  T J Kelley; L Al-Nakkash; C U Cotton; M L Drumm
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Antisense oligodeoxynucleotide to the cystic fibrosis transmembrane conductance regulator inhibits cyclic AMP-activated but not calcium-activated cell volume reduction in a human pancreatic duct cell line.

Authors:  H Kopelman; C Gauthier; M Bornstein
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents.

Authors:  J A Wagner; T V McDonald; P T Nghiem; A W Lowe; H Schulman; D C Gruenert; L Stryer; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 6.  Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Authors:  Steven M Rowe; Frank Accurso; John P Clancy
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

7.  Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis.

Authors:  J M McGill; D M Williams; C M Hunt
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.